ClinicalTrials.Veeva

Menu

IVL for Stent Underexpantsion (IVL-DRAGON)

M

Medical University of Silesia

Status

Completed

Conditions

In Stent Restenosis
Intravascular Lithotripsy
Coronary Artery Calcification

Treatments

Device: Percutaneous Coronary Intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The IVL-Dragon Registry was a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL in high-volume PCI centers. The primary efficacy endpoint was clinical success, defined as a reduction of stent underexpansion to <30% with no evidence of in-hospital device-oriented composite end point (DOCE) (defined as a composite of cardiac death, target lesion revascularization, and target vessel myocardial infarction).

Enrollment

62 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stent underexpansion treated with intravascular lithotripsy (IVL)

Exclusion criteria

  • no

Trial contacts and locations

16

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems